(Q39388641)
Statements
Clinically meaningful response to the EGFR tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in non small cell lung cancer (English)
A. Gelibter
A. Ceribelli
M. Milella
M. Mottolese
A. Vocaturo
1 September 2003